G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound
SCIE
SCOPUS
- Title
- G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound
- Authors
- Kim, YH; Shin, KJ; Lee, TG; Kim, E; Lee, MS; Ryu, SH; Suh, PG
- Date Issued
- 2005-05-01
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Abstract
- We screened a library of 11,000 small molecular weight chemicals, looking for compounds that affect cell viability. We have identified 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS) as a potent cytotoxic compound that induces cell cycle arrest and apoptosis. Treatment of Jurkat T cells with QBS increased the levels of cyclin B I as well as phosphorylated-cdc2, which was accompanied by reduced activity of cdc2 kinase, suggesting that QBS may induce cell cycle arrest at G2 phase. Structural analogues of QBS also exhibited similar effects on cell cycle progression and cell viability. Long-term treatment with QBS resulted in DNA fragmentation, cytochrome C release, and PARP cleavage, and an increase in the number of subdiploidy cells, indicative of cellular apoptosis. Moreover, QBS-induced apoptosis was blocked by z-VAD-fmk, a pan-caspase inhibitor. These results suggest that QBS is a novel and potent compound that induces G2 arrest and subsequent apoptosis, implicating it as a putative candidate for chemotherapy. (c) 2005 Elsevier Inc. All rights reserved.
- Keywords
- library screening; quinolinesulfonamide; DNA damage; G2 arrest; apoptosis; CARBONIC-ANHYDRASE INHIBITORS; DNA-DAMAGE; CELL-CYCLE; NUCLEAR-LOCALIZATION; ANTITUMOR AGENTS; ASSAY; SULFONAMIDES; DEATH; P53; B1
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/24628
- DOI
- 10.1016/j.bcp.2004.12.019
- ISSN
- 0006-2952
- Article Type
- Article
- Citation
- BIOCHEMICAL PHARMACOLOGY, vol. 69, no. 9, page. 1333 - 1341, 2005-05-01
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.